Tag: treat

A new drug that inhibits neonatal seizures in rodent models could open up new avenues for the treatment of epilepsy in human newborns. Researchers have identified that gluconate—a small organic compound found in fruit and honey—acts as an anticonvulsant, inhibiting seizures by targeting the activity of channels that control the flow of chloride ions in

Drugs used to target HER2-positive invasive breast cancer may also be successful in treating women in the first stages of the disease, researchers at The University of Nottingham have discovered. The findings, published in the British Journal of Cancer and led by experts in the University’s School of Medicine, suggest that extending anti-HER2 drugs to

Ask a parent — any parent — how they manage technology and kids’ screen time in their household, and you’ll hear a range of philosophies. And that’s because there’s no one-size-fits-all answer. “It’s easy to focus on the risks and limitations,” Polly Palumbo, psychologist and founder of MommaData, tells SheKnows. In that regard, she says

Diagnosing autism can take half a day or more of clinical observation, and that’s the quick part – often, families wait years just to get to that point. Now, in hopes of speeding things up, Stanford researchers are developing a smartphone app that could drastically reduce the time it takes to get a diagnosis. The

Understanding and mitigating the role of epigenetics (environmental influences that trigger changes in gene expression) in disease development is a major goal of researchers. Now, a newly published paper featured on the March cover of the journal Brain adds significantly to this work by detailing how metabolites can be used to inhibit epigenetic mechanisms and

Controversial electric shock therapy approved on the NHS to treat depression is not safe and should be stopped, leading researcher argues Electroconvulsive or ‘shock’ therapy induces seizures to treat mental illnesses Professor John Read said its use is based on positive studies as old as 30 years  It can cause memory loss and has been badly

January 2, 2019—As early as 3 months of age, infants with a severe form of epilepsy called Dravet syndrome start having convulsive seizures, during which their arms and legs jerk repeatedly. As they become toddlers, another type of seizure begins to appear. These seizures do not cause obvious convulsions, but disrupt consciousness and can occur

We don’t know about you, but we really love oatmeal. It makes for a cozy five-minute breakfast in winter months, and cold overnight oats are easy and refreshing in the summer (although, TBH, we mostly stick to hot oats all year). And we still can’t get over the fact that something so easy and inexpensive

Hope of a Parkinson’s breakthrough as experts transplant MILLIONS of stem cells into a patient’s brain ‘to regrow parts ravaged by the disease’ Experts at Kyoto University in Japan performed the first-of-its-kind procedure The man is in his 50s and is one of seven people who will take part in the trial  The procedure has

Pin Kids love Halloween — or at least the dressing up and getting candy part. But should teens or even college-age kids really be out there trick-or-treating with the little kids?  Child psychologist Michele Borba tells SheKnows that while there’s no one-size strict age cutoff, most kids decide that between 12 and 17 they feel

Engineers and medical researchers at the University of Minnesota have teamed up to create a groundbreaking 3-D-printed device that could someday help patients with long-term spinal cord injuries regain some function. A 3-D-printed guide, made of silicone, serves as a platform for specialized cells that are then 3-D printed on top of it. The guide

Bile acids that aid fat digestion are also found to reduce the rewarding properties of cocaine use, according to a study publishing on July 26 in the open-access journal PLOS Biology by India Reddy, Nicholas Smith, and Robb Flynn of Vanderbilt University, Aurelio Galli of the University of Alabama at Birmingham, and colleagues. The results

Increasingly, doctors are treating lung cancer based on the genetic rearrangements driving the disease. For example, cancers that are driven by changes in the genes ALK, EGFR, and ROS1 can now all be paired with drugs that target these specific changes. However, these cancers are not only dangerous in the lung where they appear, but

Alzheimer’s disease (AD) is the most common form of dementia. It takes a devastating toll on patients and family members, who are usually the caregivers. Current drugs only treat symptoms of AD, not its causes. FIU researchers are studying a new approach to treating Alzheimer’s using nanotechnology aimed at reducing the inflammation in the brain.

The drug — which is activated by shining light down an optical fiber implanted in the brain — reduced Parkinson’s symptoms and improved motor function in mice. In a paper about the work now published in the Journal of Controlled Release, the international team suggests that the “light-operated” drug could potentially treat other movement disorders.

Researchers from the Papua New Guinea Institute for Medical Research and UNSW’s Kirby Institute say health services are needed to tackle high rates of HIV, hepatitis and STIs among key populations in PNG. Expanded health and social services are needed to urgently address HIV in Papua New Guinea, according to new research conducted by the

Patients with stroke caused by bleeding on the brain (intracerebral haemorrhage) may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed. The study, led by experts at The University of Nottingham and funded by the National Institute for Health Research (NIHR)

Spinal muscular atrophy (SMA) is a genetic disease that can leave infants with weak muscles and trouble breathing. Many with the disease die before age two. To help these patients, doctors need therapies that target the genetic mutation and stop its progression. Now, scientists at the California Institute for Biomedical Research (Calibr) and The Scripps

A new drug could ease the distress of men and women who suffer from baldness, according to researchers from The University of Manchester’s Centre for Dermatology Research. The study from the laboratory of Prof Ralf Paus, is published today (8 May) in the open access journal PLOS Biology It shows that a drug originally designed

Researchers have discovered a new family of substances which has been found to display highly potent activity against the release of pro-inflammatory cytokines and the toxicity induced by reactive oxygen species (ROS). The novel compounds synthesized and evaluated belong to a family of low molecular weight substances named indolines. In early experiments, these compounds have